Relmada Therapeutics Stock Pattern Recognition Ladder Bottom
| RLMD Stock | USD 3.83 0.28 7.89% |
| Symbol |
Recognition |
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The function did not return any valid pattern recognition events for the selected time horizon. The Ladder Bottom is a reversal pattern describing Relmada Therapeutics bullish trend.
Relmada Therapeutics Technical Analysis Modules
Most technical analysis of Relmada Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Relmada from various momentum indicators to cycle indicators. When you analyze Relmada charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Relmada Therapeutics Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Relmada Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Relmada Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Relmada Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Relmada Therapeutics's daily price indicators and compare them against related drivers, such as pattern recognition and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Relmada Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Relmada Therapeutics, we also check how macroeconomic factors affect Relmada Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2018 | 2019 | 2025 | 2026 (projected) | Payables Turnover | 0.005269 | 0.83 | 0.95 | 1.0 | Days Of Inventory On Hand | 34.4K | 403.14 | 362.83 | 344.69 |
Align your values with your investing style
In addition to having Relmada Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Artificial Intelligence Invested few shares | |
 | Manufacturing Invested over 60 shares | |
 | Macroaxis Index Invested over 40 shares | |
 | Blockchain Invested few shares | |
 | ESG Investing Invested few shares | |
 | Momentum Invested over 30 shares | |
 | Hedge Favorites Invested over 200 shares | |
 | Warren Buffett Holdings Invested over 20 shares | |
 | Impulse Invested over 200 shares | |
 | Advertising Invested few shares | |
 | Diversified Assets Invested over 50 shares | |
 | Power Assets Invested over 200 shares | |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Relmada Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For information on how to trade Relmada Stock refer to our How to Trade Relmada Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Will Pharmaceuticals sector continue expanding? Could Relmada diversify its offerings? Factors like these will boost the valuation of Relmada Therapeutics. Anticipated expansion of Relmada directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Relmada Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Relmada Therapeutics's market price often diverges from its book value, the accounting figure shown on Relmada's balance sheet. Smart investors calculate Relmada Therapeutics' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Relmada Therapeutics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Relmada Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Relmada Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Relmada Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.